| Literature DB >> 34160272 |
Sherry Mou1, Conor C Jenkins2,3, Udoka Okaro1, Elizabeth S Dhummakupt3, Phillip M Mach3, David DeShazer1.
Abstract
Burkholderia pseudomallei is an opportunistic pathogen that is responsible for the disease melioidosis in humans and animals. The microbe is a tier 1 select agent because it is highly infectious by the aerosol route, it is inherently resistant to multiple antibiotics, and no licensed vaccine currently exists. Naturally acquired infections result from contact with contaminated soil or water sources in regions of endemicity. There have been few reports investigating the molecular mechanism(s) utilized by B. pseudomallei to survive and persist in ecological niches harboring microbial competitors. Here, we report the isolation of Gram-positive bacteria from multiple environmental sources and show that ∼45% of these isolates are inhibited by B. pseudomallei in head-to-head competition assays. Two competition-deficient B. pseudomallei transposon mutants were identified that contained insertion mutations in the hmqA-G operon. This large biosynthetic gene cluster encodes the enzymes that produce a family of secondary metabolites called 4-hydroxy-3-methyl-2-alkylquinolines (HMAQs). Liquid chromatography and mass spectrometry conducted on filter-sterilized culture supernatants revealed five HMAQs and N-oxide derivatives that were produced by the parental strain but were absent in an isogenic hmqD deletion mutant. The results demonstrate that B. pseudomallei inhibits the growth of environmental Gram-positive bacteria in a contact-independent manner via the production of HMAQs by the hmqA-G operon. IMPORTANCE Burkholderia pseudomallei naturally resides in water, soil, and the rhizosphere and its success as an opportunistic pathogen is dependent on the ability to persist in these harsh habitats long enough to come into contact with a susceptible host. In addition to adapting to limiting nutrients and diverse chemical and physical challenges, B. pseudomallei also has to interact with a variety of microbial competitors. Our research shows that one of the ways in which B. pseudomallei competes with Gram-positive environmental bacteria is by exporting a diverse array of closely related antimicrobial secondary metabolites.Entities:
Keywords: HMAQ; melioidosis; microbial competition
Mesh:
Substances:
Year: 2021 PMID: 34160272 PMCID: PMC8552763 DOI: 10.1128/Spectrum.00102-21
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
FIG 1Phylogenetic tree based on partial 16S rRNA sequences of Gram-positive bacterial isolates from soil (S), river water (R), river sediment (RS), stream water (ST), and rhizosphere (RZ) samples. NGPhylogeny.fr was used to build the tree in “FastME/OneClick” mode, and it utilized MAFFT for multiple alignment, BMGE for automatic alignment curation, FastME for tree inference, and Newick Display for tree rendering (65). The sequence of the B. pseudomallei 16S rRNA gene was used as an outgroup. The scale bar indicates the number of substitutions per site.
FIG 2Contact-mediated competition assay used in this study. (A) Qualitative observation of bacterial competition between B. pseudomallei and Gram-positive environmental bacteria. Bacteria were grown to stationary phase in liquid broth and diluted to ∼1 × 107 CFU/ml, and aliquots of B. pseudomallei (10 μl), environmental competitor (10 μl), and a 1:1 mixture of B. pseudomallei plus competitor (20 μl) were spotted onto LB agar with or without X-Gal and incubated for 48 h at RT (left). The appearance of competition assays conducted with four different environmental competitors is shown. The competition mixtures that remain an off-white color indicate that B. pseudomallei is able to inhibit the competitor, and the mixtures that are pigmented or blue indicate that B. pseudomallei is unable to eliminate the competitor. (B) Quantitative assessment of bacterial competition between B. pseudomallei and Gram-positive environmental bacteria. The bacterial spots were resuspended in PBS, serially diluted, and spread onto agar plates to determine the number of viable bacteria present. The appearance of agar plates from three different B. pseudomallei plus competitor mixtures are shown. B. pseudomallei colonies are off-white in color and can be easily distinguished from competitors that produce β-galactosidase (left) or competitors that are pigmented (center and right).
Results of contact-mediated competition assays between B. pseudomallei Bp82 and Gram-positive environmental isolates
| Environmental isolate | Bp82 outcomes in mixed culture | Outcompetes Bp82 in mixed culture | Fold difference |
|---|---|---|---|
| X | 117 ± 3 | ||
| X | 60 ± 18 | ||
| X | 111 ± 14 | ||
| X | 14 ± 4 | ||
| X | 2 ± 0.4 | ||
| ND | |||
| X | 124 ± 43 | ||
| X | 149 ± 25 | ||
| ND | |||
| ND | |||
| X | 42 ± 2 | ||
| ND | |||
| X | 12 ± 3 | ||
| X | 51 ± 12 |
Fold difference between the Bp82/environmental isolate ratio when the bacteria are grown in mixed culture compared to when the bacteria are grown alone. Three independent pairs of cultures were performed for each Bp82-environmental isolate competition assay, and the results were recorded as the mean ± the standard deviation.
ND, no significant difference in competitive index in mixed growth relative to solitary growth.
FIG 3B. pseudomallei Bp82 inhibits N. bataviensis S4 in a contact-independent manner. (A) Bp82 competition assay with S4 on solid medium (contact mediated). (B) Bp82 competition assay with S4 in broth medium (contact independent). Three independent pairs of cultures were performed for each competition assay, and the results were recorded as the mean ± the standard deviation. (C) Bp82 culture supernatant contains a filterable antimicrobial product(s) that inhibits S4 growth. A Bp82 colony was inoculated on an S4 lawn on LB agar with X-Gal, and it produced a zone of inhibition around the colony (left); the growth of the S4 lawn was also inhibited by 5-μl and 10-μl aliquots of filter-sterilized Bp82 culture supernatant (right). **, P < 0.01; ***, P < 0.001.
FIG 4The B. pseudomallei hmqA-G locus mediates antimicrobial activity against N. bataviensis and other Gram-positive environmental species. (A) Genetic map of the hmqA-G gene cluster, locus tags BP1026B_II0535-BP1026B_II0541 in B. pseudomallei 1026b and BPSS0481-BPSS0487 in B. pseudomallei K96243. The location and direction of transcription of genes are represented by arrows. The location of TnMod-OKm′ insertions in SMM1 and SMM2 are shown schematically by round-top push pins. The unlinked hmqL gene, locus tag BP1026B_II2272 in 1026b and BPSS2111 in K96243, is not shown. A 1-kb scale is shown at the bottom. (B) Bp82 produces a zone of inhibition on a lawn of S4, but SMM1 and SMM2 are unable to produce such zones. (C) The deletion mutations in B. pseudomallei Bp82 ΔhmqA, Bp82 ΔhmqD, and Bp82 ΔhmqF do not produce zones of inhibition on a lawn of S4. The inoculated LB agar plates containing X-Gal were incubated for 48 h at RT.
Strains, plasmids, and primers used in this study
| Strain or plasmid | Relevant characteristics or sequence (5′→3′) | Source or Reference |
|---|---|---|
| Strains | ||
| | ||
| TOP10 | General cloning and blue/white screening | Life Technologies |
| | General cloning and blue/white screening | Lucigen |
| S17-1 | Mobilizing strain with transfer genes of RP4 integrated on chromosome, Smr, Tpr |
|
| INV110 | Invitrogen | |
| | ||
| 1026b | Isolated in Thailand from a human case of septicemic melioidosis with skin, soft tissue, and spleen involvement, Pmr |
|
| Bp82 | 1026b Δ |
|
| SMM1 | Bp82 derivative, | This study |
| SMM2 | Bp82 derivative, | This study |
| Bp82 Δ | Bp82 derivative harboring a 438-bp in-frame deletion mutation in | This study |
| Bp82 Δ | Bp82 derivative harboring a 318-bp in-frame deletion mutation in | This study |
| Bp82 Δ | Bp82 derivative harboring a 948-bp in-frame deletion mutation in | This study |
| K96243 | Isolated in Thailand from a diabetic patient with a clinical history of short incubation, septicemic infection, and rapid progression to death |
|
| MSHR346 | Isolated in 1995 from the sputum of a melioidosis patient admitted to Royal Darwin Hospital, Northern Territory, Australia | P. Keim |
| Plasmids | ||
| pCR2.1-TOPO | 3,931-bp TA vector, pMB1 | Life Technologies |
| pCR2.1- | pCR2.1-TOPO containing 1,639-bp PCR product generated with hmqA-up and hmqA-dn | This study |
| pCR2.1-Δ | pCR2.1- | This study |
| pCR2.1- | pCR2.1-TOPO containing 1,142-bp PCR product generated with hmqD-up and hmqD-dn | This study |
| pCR2.1-Δ | pCR2.1- | This study |
| pCR2.1- | pCR2.1-TOPO containing 1,995-bp PCR product generated with hmqF-up and hmqF-dn | This study |
| pTn | Minitransposon vector, pMB1 |
|
| pSMM1No | Plasmid obtained from SMM1 by | This study |
| pSMM2No | Plasmid obtained from SMM2 by | This study |
| pMo130 | Suicide vector for allelic exchange in |
|
| pMo130-Δ | pMo130 containing the NheI insert from pCR2.1-Δ | This study |
| pMo130-Δ | pMo130 containing the SpeI-XbaI insert from pCR2.1-Δ | This study |
| pMo130- | pMo130 containing the SpeI-XbaI insert from pCR2.1- | This study |
| pMo130-Δ | pMo130- | This study |
| pBHR2 | Broad-host-range plasmid, Kmr |
|
| pBHR2- | pBHR2 containing EcoRI insert from pCR2.1- | This study |
| pBHR2- | pBHR2 containing EcoRI insert from pCR2.1- | This study |
| pBHR2- | pBHR2 containing EcoRI insert from pCR2.1- | This study |
| Primers | ||
| 553F |
|
|
| 1492R |
|
|
| Rd1 |
|
|
| Fd1 |
|
|
| M13 Forward |
| Life Technologies |
| M13 Reverse |
| Life Technologies |
| TnMod-LT2 |
| This study |
| hmqA-up |
| This study |
| hmqA-dn |
| This study |
| hmqD-up |
| This study |
| hmqD-dn |
| This study |
| hmqF-up |
| This study |
| hmqF-dn |
| This study |
r, resistant; s, susceptible; Sm, streptomycin; Tp, trimethoprim; Pm, polymyxin B; Km, kanamycin; Ap, ampicillin.
FIG 5The in-frame ΔhmqD mutation can be complemented by hmqD when supplied in trans on the broad-host-plasmid pBHR2. Bp82 ΔhmqD (pBHR2) and Bp82 ΔhmqD (pBHR2-hmqD) were mixed with S4, and competitive indexes were assessed in contact-mediated competition assays (38). S4 outcompeted Bp82 ΔhmqD (pBHR2) by 25-fold, but Bp82 ΔhmqD (pBHR2-hmqD) outcompeted S4 by 53-fold. The mixtures were incubated at RT for 48 h on solid medium, and the surviving competitors were quantitated. Three independent pairs of cultures were performed for each competition assay, and the results were recorded as the mean ± the standard deviation. *, P < 0.05.
FIG 6B. pseudomallei outcompetes environmental Gram-positive bacteria in an hmqD-dependent manner. Contact-mediated competition assays were performed with B. pseudomallei Bp82, Bp82 ΔhmqD, and N. bataviensis S4 (A), B. velezensis RZ8 (B), B. licheniformis S7 (C), B. mycoides R15 (D), Microbacterium sp. RS16 (E), and Cellulosimicrobium sp. RS17 (F). The fold difference between the B. pseudomallei/environmental isolate ratio when the bacteria were grown alone (solitary growth ratio) or in mixed culture (mixed culture ratio) was used to establish the competitive indexes. The bacteria were incubated at RT for 48 h on solid medium, and the surviving competitors were quantitated. Three independent pairs of cultures were performed for each competition assay, and the results were recorded as the mean ± the standard deviation. NS, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
FIG 7B. pseudomallei Bp82 supernatant contains 4-hydroxy-3-methyl-2-alkenylquinolines (HMAQs) and their N-oxide counterparts (HMAQ-NOs) that are absent in Bp82 ΔhmqD supernatant. (A) Chromatograms of Bp82 and Bp82 ΔhmqD supernatant extracts. Chromatographic retention times for the compounds of interest are indicated by vertical arrows. Associated mass spectra for these retention times are shown in panels B to F. Fragmentation spectra and precursor mass structure of HMAQ-C7:1 (B), HMAQ-C7:1 N-oxide (C), HMAQ-C8:1 (D), HMAQ-C9:1 (E), and HMAQ-C9:1 N-oxide (F). The HMAQ derivatives shown in B to F all possess alkyl chains that are unsaturated with the double bond at position 1′. (G) Tabulated data identifying the molecular formula, weight, and chromatographic area counts associated with the mass of interest.